A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222

Clinical trial NCT03969888 · COMPLETED

Trial details

NCT number: NCT03969888
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2019-12-11
Primary completion: 2022-06-09
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.